{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T11:08:27Z","timestamp":1788260907063,"version":"build-2803163510"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13104-018-4021-2","type":"journal-article","created":{"date-parts":[[2018,12,26]],"date-time":"2018-12-26T19:20:02Z","timestamp":1545852002000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Affordability of commonly prescribed antibiotics in a large tertiary teaching hospital in Ethiopia: a challenge for the national drug policy objective"],"prefix":"10.1186","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9811-4521","authenticated-orcid":false,"given":"Girma","family":"Gutema","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ephrem","family":"Engidawork","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,12,27]]},"reference":[{"key":"4021_CR1","unstructured":"WHO. Essential medicines 2015. \n                    http:\/\/www.who.int\/medicines\/services\/essmedicines_def\/en\/\n                    \n                  . Accessed 25 Jan 2018."},{"key":"4021_CR2","unstructured":"WHO. Essential medicines and health products 2007. \n                    http:\/\/www.who.int\/medicines\/events\/fs\/en\/\n                    \n                  . Accessed 25 Jan 2018."},{"key":"4021_CR3","unstructured":"WHO. WHO Medium-term strategic plan 2008\u20132013; plan M-TS. 2008\u20132013. 2008. \n                    http:\/\/www2.wpro.who.int\/internet\/resources.ashx\/RCM\/rc59\/MTSP_08-13-en_7August08.pdf\n                    \n                  . Accessed 11 Oct 2017."},{"key":"4021_CR4","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s40545-017-0123-9","volume":"10","author":"D Kibira","year":"2017","unstructured":"Kibira D, Kitutu F, Merrett G, Mantel-Teeuwisse A. Availability, prices and affordability of UN Commission\u2019s lifesaving medicines for reproductive and maternal health in Uganda. J Pharm Policy Pract. 2017;10:35.","journal-title":"J Pharm Policy Pract"},{"key":"4021_CR5","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/S0140-6736(08)61762-6","volume":"373","author":"A Cameron","year":"2009","unstructured":"Cameron A, Ewen M, Ross-Degnan D, Ball D, Laing R. Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis. Lancet. 2009;373:240\u20139.","journal-title":"Lancet"},{"key":"4021_CR6","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s11096-009-9282-3","volume":"31","author":"A Cheraghali","year":"2009","unstructured":"Cheraghali A, Idries A. Availability, affordability, and prescribing pattern of medicines in sudan. Pharm World Sci. 2009;31:209\u201315.","journal-title":"Pharm World Sci"},{"issue":"4","key":"4021_CR7","doi-asserted-by":"publisher","first-page":"e0175399","DOI":"10.1371\/journal.pone.0175399","volume":"12","author":"F Khuluza","year":"2017","unstructured":"Khuluza F, Heide L. Availability and affordability of antimalarial and antibiotic medicines in Malawi. PLoS ONE. 2017;12(4):e0175399.","journal-title":"PLoS ONE"},{"key":"4021_CR8","doi-asserted-by":"publisher","first-page":"412","DOI":"10.2471\/BLT.10.084327","volume":"89","author":"A Cameron","year":"2011","unstructured":"Cameron A, Roubos I, Ewen M, Mantel-Teeuwisse A, Leufkens H, Laing R. Differences in the availability of medicines for chronic and acute conditions in the public and private sectors of developing countries. Bull World Health Organ. 2011;89:412\u201321.","journal-title":"Bull World Health Organ"},{"key":"4021_CR9","doi-asserted-by":"publisher","first-page":"571","DOI":"10.4269\/ajtmh.2010.10-0100","volume":"83","author":"E Chomba","year":"2010","unstructured":"Chomba E, Haworth A, Mbewe E, Atadzhanov M, Ndubani P, Kansembe H, Birbeck G. The current availability of antiepileptic drugs in zambia: implications for the ILAE\/WHO \u2018\u2018out of the shadows\u2019\u2019 campaign. Am J Trop Med Hyg. 2010;83:571\u20134.","journal-title":"Am J Trop Med Hyg"},{"key":"4021_CR10","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1159\/000103270","volume":"28","author":"P Odermatt","year":"2007","unstructured":"Odermatt P, Ly S, Simmala C, Angerth T, Phongsamouth V, Mac T, Ratsimbazafy V, Gaulier J, Strobel M, Preux P. Availability and costs of antiepileptic drugs and quality of phenobarbital in vientiane municipality, lao PDR. Neuroepidemiology. 2007;28:169\u201374.","journal-title":"Neuroepidemiology"},{"key":"4021_CR11","doi-asserted-by":"publisher","first-page":"96S","DOI":"10.1177\/1010539510373005","volume":"22","author":"M Higuchi","year":"2010","unstructured":"Higuchi M. Access to diabetes care and medicines in the philippines. Asia Pac J Public Health. 2010;22:96S\u2013102S.","journal-title":"Asia Pac J Public Health"},{"key":"4021_CR12","unstructured":"Tansitional Government of Ethiopia. National Drug Policy of the Transitional Government of Ethiopia, 1993 [English version], p. 16\u201317, Addis Ababa."},{"key":"4021_CR13","doi-asserted-by":"publisher","first-page":"4551","DOI":"10.2147\/DDDT.S83588","volume":"9","author":"T Summoro","year":"2015","unstructured":"Summoro T, Gidebo K, Kanche Z, Woticha E. Evaluation of trends of drug-prescribing patterns based on WHO prescribing indicators at outpatient departments of four hospitals in southern Ethiopia. Drug Des Devel Ther. 2015;9:4551\u20137.","journal-title":"Drug Des Devel Ther"},{"key":"4021_CR14","unstructured":"Food Medicine and Healthcare Administration and Control authority of Ethiopia. National Essential Medicine List, Fifth Edition, p. 1\u201331, Addis Ababa, 2014."},{"key":"4021_CR15","unstructured":"Federal Ministry of Health, Drug Administration and Control Authority. Guidelines on Management and Operation of Special Pharmacies, Addis Ababa. 2002."},{"issue":"2","key":"4021_CR16","doi-asserted-by":"publisher","first-page":"139","DOI":"10.2471\/BLT.07.048561","volume":"87","author":"G Ali","year":"2009","unstructured":"Ali G. How to establish a successful revolving drug fund: the experience of Khartoum state in the Sudan. Bull World Health Organ. 2009;87(2):139\u201342.","journal-title":"Bull World Health Organ"},{"key":"4021_CR17","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12887-016-0572-3","volume":"16","author":"E Sado","year":"2016","unstructured":"Sado E, Sufa A. Availability and affordability of essential medicines for children in the Western part of Ethiopia: implication for access. BMC Pediatr. 2016;16:40.","journal-title":"BMC Pediatr"},{"issue":"11","key":"4021_CR18","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1111\/j.1365-3156.2009.02383.x","volume":"14","author":"B Carasso","year":"2009","unstructured":"Carasso B, Lagarde M, Tesfaye A, Palmer N. Availability of essential medicines in Ethiopia: an efficiency-equity trade-off? Trop Med Int Health. 2009;14(11):1394\u2013400.","journal-title":"Trop Med Int Health"},{"issue":"10","key":"4021_CR19","first-page":"101","volume":"3","author":"Z Abiye","year":"2013","unstructured":"Abiye Z, Tesfaye A, Hawaze S. Barriers to access: availability and affordability of essential drugs in a retail outlet of a public health center in south western Ethiopia. JAPS. 2013;3(10):101\u20135.","journal-title":"JAPS"},{"issue":"1","key":"4021_CR20","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.4102\/phcfm.v6i1.604","volume":"6","author":"B Mhlanga","year":"2014","unstructured":"Mhlanga B, Suleman F. Price, availability and affordability of medicines. Afr J Prim Health Care Fam Med. 2014;6(1):E1\u20136.","journal-title":"Afr J Prim Health Care Fam Med"},{"issue":"8","key":"4021_CR21","doi-asserted-by":"publisher","first-page":"e000333","DOI":"10.1371\/journal.pmed.1000333","volume":"7","author":"L Niens","year":"2010","unstructured":"Niens L, Cameron A, Van de Poel E, Ewen M, Brouwer W, Laing R. Quantifying the impoverishing effects of purchasing medicines: a cross-country comparison of the affordability of medicines in the developing world. PloS Med. 2010;7(8):e000333.","journal-title":"PloS Med"},{"key":"4021_CR22","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/S0140-6736(06)69560-3","volume":"368","author":"E Doorslaer van","year":"2006","unstructured":"van Doorslaer E, O\u2019Donnell O, Rannan-Eliya R, Somanathan A, Adhikari S, et al. Effect of payments for health care on poverty estimates in 11 countries in Asia: an analysis of household survey data. Lancet. 2006;368:1357\u201364.","journal-title":"Lancet"},{"key":"4021_CR23","doi-asserted-by":"publisher","first-page":"353","DOI":"10.2147\/CEOR.S136508","volume":"9","author":"S Workneh","year":"2017","unstructured":"Workneh S, Biks G, Woreta S. Community-based health insurance and communities\u2019 scheme requirement compliance in Thehuldere district, northeast Ethiopia: cross-sectional community-based study. Clinicoecon Outcomes Res. 2017;9:353\u20139.","journal-title":"Clinicoecon Outcomes Res"},{"key":"4021_CR24","unstructured":"The World Bank: Out-of-pocket health expenditure (% of private expenditure on health): Overview per country\u2013Ethiopia, 2014. \n                    https:\/\/data.worldbank.org\/indicator\/SH.XPD.OOPC.CH.ZS?locations=ET\n                    \n                  . Accessed 10 Sept 2017."},{"key":"4021_CR25","unstructured":"The World Bank: Poverty and equity data portal: country indicators\u2014Ethiopia. 2011. \n                    http:\/\/povertydata.worldbank.org\/poverty\/country\/ETH\n                    \n                  . Accessed 10 Sept 2017."},{"issue":"1","key":"4021_CR26","doi-asserted-by":"publisher","first-page":"35","DOI":"10.4314\/ejhd.v18i1.9863","volume":"18","author":"T Abula","year":"2004","unstructured":"Abula T, Kedir M. The pattern of antibiotic usage in surgical inpatients of a teaching hospital, northwest Ethiopia. Ethiop J Health Dev. 2004;18(1):35\u20138.","journal-title":"Ethiop J Health Dev"},{"issue":"170","key":"4021_CR27","first-page":"1","volume":"13","author":"AA Desalegn","year":"2013","unstructured":"Desalegn AA. Assessment of drug use pattern using WHO prescribing indicators at Hawassa University teaching and referral hospital, south Ethiopia: a cross-sectional study. BMC Health Serv Res. 2013;13(170):1\u20136.","journal-title":"BMC Health Serv Res"},{"issue":"326","key":"4021_CR28","first-page":"1","volume":"8","author":"G Gutema","year":"2018","unstructured":"Gutema G, H\u00e5konsen H, Engidawork E, Toverud EL. Multiple challenges of antibiotic use in a large hospital in Ethiopia\u2014a ward-specific study showing high rates of hospital-acquired infections and ineffective prophylaxis. BMC Health Serv Res. 2018;8(326):1\u20137.","journal-title":"BMC Health Serv Res"},{"issue":"3","key":"4021_CR29","doi-asserted-by":"publisher","first-page":"e0173290","DOI":"10.1371\/journal.pone.0173290","volume":"12","author":"H Kebede","year":"2017","unstructured":"Kebede H, Gesesew H, Woldehaimanot T, Goro K. Antimicrobial use in paediatric patients in a teaching hospital in Ethiopia. PLoS ONE. 2017;12(3):e0173290.","journal-title":"PLoS ONE"},{"key":"4021_CR30","unstructured":"WHO, HAI. Measuring medicine prices, availability, affordability and price components, 2nd edition, 2008, p1-181. \n                    http:\/\/www.who.int\/medicines\/areas\/access\/OMS_Medicine_prices.pdf\n                    \n                  . Accessed 4 Oct 2017."},{"key":"4021_CR31","unstructured":"Food Medicine and Healthcare Administration and Control authority of Ethiopia. Standard treatment guidelines for general hospitals, Addis Ababa, 2014."},{"key":"4021_CR32","unstructured":"Infectious Disease Society of America: Infections by Organ System, 2007\u20132016. \n                    http:\/\/www.idsociety.org\/Organ_System\/\n                    \n                   Accessed 3 Oct 2017."},{"key":"4021_CR33","unstructured":"Management Sciences for Health: International Drug Price Indicator Guide, 2014 Edition. Medford, Mass."},{"key":"4021_CR34","unstructured":"Commercial Bank of Ethiopia: Exchange Rate, USD to ETB. 2015. \n                    http:\/\/www.combanketh.et\/More\/CurrencyRate\/tabid\/110\/ctl\/Summariz%20Exchange%20Rate\/mid\/535\/Default.aspx\n                    \n                  . Accessed 30 Apr 2015."},{"issue":"3","key":"4021_CR35","doi-asserted-by":"publisher","first-page":"259","DOI":"10.4314\/ejhs.v26i3.9","volume":"26","author":"S Suleman","year":"2016","unstructured":"Suleman S, Woliyi A, Woldemichael K, Tushune K, Duchateau L, Degroote A, Vancauwenberghe R, Bracke N, Spiegeleer B. Pharmaceutical regulatory framework in Ethiopia: a critical evaluation of its legal basis and implementation. Ethiop J Health Sci. 2016;26(3):259\u201376.","journal-title":"Ethiop J Health Sci"},{"issue":"2","key":"4021_CR36","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3325\/cmj.2012.53.173","volume":"53","author":"F Baratta","year":"2012","unstructured":"Baratta F, Germano A, Brusa P. Diffusion of counterfeit drugs in developing countries and stability of galenics stored for months under different conditions of temperature and relative humidity. Croat Med J. 2012;53(2):173\u201384.","journal-title":"Croat Med J"},{"key":"4021_CR37","unstructured":"INTERPOL. Addis Ababa declaration supports fight against fake medicines across Africa. 2013. \n                    https:\/\/www.interpol.int\/News-and-media\/News\/2013\/N20131216\n                    \n                   Accessed 23 Dec 2017."},{"key":"4021_CR38","unstructured":"EU, ACP, WHO: Renewed partnetship: strengthening pharmaceutical systems and improving access to quality medicines Ethiopia 2012\u20132016, 2016. \n                    http:\/\/www.who.int\/medicines\/areas\/coordination\/Ethiopia-brochure.pdf\n                    \n                  . Accessed 30 Jan 2018."},{"key":"4021_CR39","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1186\/1471-2458-14-817","volume":"14","author":"P Dabare","year":"2014","unstructured":"Dabare P, Wanigatunge C, Beneragama B. A national survey on availability, price and affordability of selected essential medicines for non communicable diseases in Sri Lanka. BMC Public Health. 2014;14:817.","journal-title":"BMC Public Health"},{"key":"4021_CR40","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1186\/s12913-015-1008-8","volume":"15","author":"X Xi","year":"2015","unstructured":"Xi X, Li W, Li J, Zhu X, Fu C, Wei X, Chu S. A survey of the availability, prices and affordability of essential medicines in Jiangsu province, China. BMC Health Serv Res. 2015;15:345.","journal-title":"BMC Health Serv Res"},{"issue":"4","key":"4021_CR41","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1177\/1010539517700472","volume":"29","author":"H Wang","year":"2017","unstructured":"Wang H, Sun Q, Vitry A, Nguyen T. Availability, price, and affordability of selected essential medicines for chronic diseases in 11 countries of the Asia pacific region: a secondary analysis. Asia Pac J Public Health. 2017;29(4):268\u201377.","journal-title":"Asia Pac J Public Health"},{"key":"4021_CR42","volume-title":"Pharmaceutical prices in the 21st century","author":"E Ali","year":"2015","unstructured":"Ali E, Gilani A, Gedif T. Pharmaceutical Pricing in Ethiopia. In: Babar Z, editor. Pharmaceutical prices in the 21st century. London: Adis, Cham; 2015."},{"key":"4021_CR43","unstructured":"Gelders S, Ewen M, Noguchi N, Laing R. Price, availability and affordability: an international comparison of chronic disease medicines\u2014background report prepared for the WHO Planning Meeting on the Global Initiative for Treatment of Chronic Diseases held in Cairo, 2005."},{"key":"4021_CR44","volume-title":"The global partnership for development: making rhetoric a reality, MDG gap task force report","author":"United Nations","year":"2012","unstructured":"United Nations. The global partnership for development: making rhetoric a reality, MDG gap task force report. New York: United Nations; 2012."},{"key":"4021_CR45","unstructured":"Central Statistical Agency (CSA) [Ethiopia], ICF. Ethiopia demographic and health survey 2016, Addis Ababa, Ethiopia, and Rockville, Maryland, USA."},{"key":"4021_CR46","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s13756-017-0227-7","volume":"6","author":"N Gebrekirstos","year":"2017","unstructured":"Gebrekirstos N, Workneh B, Gebregiorgis Y, Misgina K, Weldehaweria N, Weldu M, Belay H. Non-prescribed antimicrobial use and associated factors among customers in drug retail outlet in central zone of Tigray, northern Ethiopia: a cross-sectional study. Antimicrob Resist Infect Control. 2017;6:70.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"2\u20133","key":"4021_CR47","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1080\/01676830902919811","volume":"28","author":"O Onakpoya","year":"2009","unstructured":"Onakpoya O, Adeoye A, Akinpelu O. Cost-related antibiotic dosage omissions-challenge for orbital cellulitis management in resource poor communities. Orbit. 2009;28(2\u20133):147\u201352.","journal-title":"Orbit"},{"key":"4021_CR48","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.jval.2012.04.004","volume":"15","author":"A Cameron","year":"2012","unstructured":"Cameron A, Mantel-Teeuwisse A, Leufkens H, Laing R. Switching from originator brand medicines to generic equivalents in selected developing countries: how much could be saved? Value Health. 2012;15:664\u201373.","journal-title":"Value Health"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-018-4021-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13104-018-4021-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-018-4021-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,26]],"date-time":"2019-12-26T19:21:05Z","timestamp":1577388065000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/s13104-018-4021-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["4021"],"URL":"https:\/\/doi.org\/10.1186\/s13104-018-4021-2","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"25 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"925"}}